• COVER STORY •
JAMJOOM PHARMA
26
EXECUTING AN EVOLUTION Tarek Hosni, CEO of family-owned Saudi pharmaceuticals giant Jamjoom Pharma, led the company through an IPO in June 2023—the largest the kingdom has seen so far this year. Now he’s looking at new product growth to make the company an international name.
BY JASON LASRADO F O R B E S M I D D L E E A S T.C O M
AUGUST 2023
